| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Kewalramani Reshma | CEO & President | Feb 23, 2024 | Option Exercise | $431.79 | 9,386 | 4,052,781 | 136,507 | Feb 27, 2024, 04:55 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Kewalramani Reshma | CEO & President | Feb 09, 2024 | Option Exercise | $422.74 | 8,255 | 3,489,719 | 162,271 | Feb 13, 2024, 05:07 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Kewalramani Reshma | CEO & President | Dec 15, 2023 | Option Exercise | $294.41 | 34,270 | 10,089,538 | 125,846 | Dec 19, 2023, 04:15 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Kewalramani Reshma | CEO & President | Dec 13, 2023 | Sale | $397.00 | 5,098 | 2,023,906 | 108,711 | Dec 15, 2023, 04:23 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Kewalramani Reshma | CEO & President | Nov 13, 2023 | Sale | $377.00 | 5,097 | 1,921,569 | 113,809 | Nov 15, 2023, 04:16 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Kewalramani Reshma | CEO & President | Jul 17, 2023 | Sale | $355.00 | 7,828 | 2,778,940 | 118,906 | Jul 18, 2023, 04:13 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Kewalramani Reshma | CEO & President | Apr 27, 2023 | Sale | $339.08 | 3,317 | 1,124,726 | 128,358 | May 01, 2023, 04:26 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Kewalramani Reshma | CEO & President | Feb 24, 2023 | Option Exercise | $289.12 | 9,386 | 2,713,680 | 129,969 | Feb 28, 2023, 04:53 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Kewalramani Reshma | CEO & President | Feb 17, 2023 | Option Exercise | $292.85 | 9,359 | 2,740,783 | 139,355 | Feb 22, 2023, 04:35 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Kewalramani Reshma | CEO & President | Feb 10, 2023 | Option Exercise | $294.33 | 3,372 | 992,481 | 154,704 | Feb 14, 2023, 04:58 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Kewalramani Reshma | CEO & President | Feb 13, 2023 | Option Exercise | $298.26 | 5,990 | 1,786,577 | 148,714 | Feb 14, 2023, 04:58 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Kewalramani Reshma | CEO & President | Jan 25, 2023 | Sale | $315.05 | 10,000 | 3,150,500 | 89,598 | Jan 27, 2023, 04:13 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Kewalramani Reshma | CEO & President | Aug 15, 2022 | Sale | $305.06 | 11,689 | 3,565,846 | 99,598 | Aug 17, 2022, 05:40 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Kewalramani Reshma | CEO & President | Jun 24, 2022 | Sale | $291.30 | 11,689 | 3,405,006 | 111,153 | Jun 28, 2022, 04:05 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Kewalramani Reshma | CEO & President | Feb 24, 2022 | Option Exercise | $227.86 | 7,246 | 1,651,074 | 122,842 | Feb 28, 2022, 05:21 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Kewalramani Reshma | CEO & President | Feb 17, 2022 | Option Exercise | $232.51 | 8,584 | 1,995,866 | 130,088 | Feb 22, 2022, 04:56 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Kewalramani Reshma | CEO & President | Feb 10, 2022 | Option Exercise | $237.74 | 3,031 | 720,590 | 138,672 | Feb 14, 2022, 04:16 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Kewalramani Reshma | CEO & President | Aug 19, 2021 | Buy | $195.65 | 10,000 | 1,956,492 | 73,754 | Aug 23, 2021, 08:30 AM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Kewalramani Reshma | CEO & President | Feb 24, 2021 | Option Exercise | $217.57 | 2,898 | 630,518 | 63,643 | Feb 26, 2021, 04:15 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Kewalramani Reshma | CEO & President | Feb 17, 2021 | Option Exercise | $211.75 | 2,080 | 440,440 | 66,541 | Feb 19, 2021, 04:12 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Kewalramani Reshma | CEO & President | Feb 10, 2021 | Option Exercise | $214.16 | 2,962 | 634,342 | 68,621 | Feb 12, 2021, 04:07 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Kewalramani Reshma | CEO & President | Aug 06, 2020 | Sale | $225.44 | 4,146 | 934,687 | 28,699 | Aug 10, 2020, 04:19 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Kewalramani Reshma | CEO & President | May 15, 2020 | Sale | $284.17 | 99 | 28,132 | 26,723 | May 19, 2020, 04:35 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Kewalramani Reshma | CEO & President | May 06, 2020 | Sale | $226.26 | 4,148 | 938,520 | 28,700 | May 08, 2020, 04:19 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Kewalramani Reshma | EVP and CMO | Feb 24, 2020 | Option Exercise | $239.23 | 2,898 | 693,289 | 30,260 | Feb 26, 2020, 04:32 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Kewalramani Reshma | EVP and CMO | Feb 25, 2020 | Sale | $233.45 | 3,634 | 848,371 | 29,367 | Feb 26, 2020, 04:32 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Kewalramani Reshma | EVP and CMO | Feb 17, 2020 | Option Exercise | $241.50 | 944 | 227,976 | 34,341 | Feb 19, 2020, 04:33 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Kewalramani Reshma | EVP and CMO | Feb 18, 2020 | Sale | $243.51 | 1,183 | 288,070 | 34,221 | Feb 19, 2020, 04:33 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Kewalramani Reshma | EVP and CMO | Feb 06, 2020 | Sale | $209.56 | 4,148 | 869,237 | 37,359 | Feb 07, 2020, 04:14 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Kewalramani Reshma | EVP and CMO | Nov 25, 2019 | Sale | $203.45 | 9,384 | 1,909,175 | 17,790 | Nov 26, 2019, 04:12 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Kewalramani Reshma | EVP and CMO | Nov 15, 2019 | Sale | $205.95 | 61 | 12,563 | 13,098 | Nov 19, 2019, 04:11 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Kewalramani Reshma | EVP and CMO | Nov 08, 2019 | Option Exercise | $177.29 | 1,018 | 180,476 | 13,607 | Nov 13, 2019, 04:08 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Kewalramani Reshma | EVP and CMO | Oct 30, 2019 | Option Exercise | $177.29 | 6,114 | 1,083,921 | 16,155 | Oct 31, 2019, 04:36 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Kewalramani Reshma | EVP and CMO | Oct 22, 2019 | Sale | $189.00 | 638 | 120,582 | 13,098 | Oct 24, 2019, 07:18 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Kewalramani Reshma | EVP and CMO | May 15, 2019 | Sale | $165.41 | 241 | 39,864 | 13,736 | May 17, 2019, 04:21 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Kewalramani Reshma | EVP and CMO | Feb 19, 2019 | Sale | $186.94 | 1,488 | 278,163 | 14,038 | Feb 21, 2019, 04:22 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Kewalramani Reshma | EVP and CMO | Oct 08, 2018 | Sale | $186.95 | 2,305 | 430,920 | 1,909 | Oct 09, 2018, 04:50 PM |
Menu